Pharma Pulse 3/26/25: COVID's Impact on Drug Discovery, Examining Healthcare Spending Across US Counties & more

Examining Healthcare Spending Across US Counties

What drivers impact the differences in expenditures?

COVID-19 5 Years Later: The Impact on Drug Discovery

As the COVID-19 pandemic moves into an endemic phase, the major impacts on drug research, collaboration, and use of new technologies due to the spread of the virus warrant recognition.

AstraZeneca Seeks to Move Past China Probe With R&D Hub

Ever since AstraZeneca Plc shocked investors in October with news its China chief was under investigation, the British pharmaceutical giant has tried to maintain a business-as-usual stance in its second-biggest market.

Comprehensive Review of More Than 400 Studies Conducted Over 30 Years

The use of self-care to address unmet medical needs could transform how vulnerable populations access treatment and knowledge, while reducing the burden on healthcare systems, according to a recently published study by Bayer’s Research Initiative for Self-Care Equity.

UpScriptHealth on LinkedIn

Our founder and CEO Peter Ax recently shared valuable insights with Miranda Schmalfuhs from Pharmaceutical Executive on how #tariffs could reshape medication costs, availability, and patient access. Check out part 1 of their interview below to learn how #telehealth innovations are creating resilient medication delivery systems in an evolving economic landscape.

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs